US2012323001A1PendingUtilityA1
Bace inhibitors
Est. expiryJul 9, 2029(~2.9 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 25/28C07D 513/02C07D 498/04C07D 279/08A61K 31/496
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides BACE inhibitors of Formula I: methods for their use, intermediates, and methods for their preparation.
Claims
exact text as granted — not AI-modified1 - 17 . (canceled)
18 . A compound which is (4aR,6R,7aS)-2-Amino-7a-(3′-methoxybiphenyl-3-yl)-4,4-a,5,6,7,7a-hexahydrocyclopenta[d][1,3]thiazin-6-ol;
or a pharmaceutically acceptable salt thereof.Join the waitlist — get patent alerts
Track US2012323001A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.